NASDAQ : CTKB

Cytek Biosciences, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 6.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 818.89M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Details

NameCytek Biosciences, Inc.
SectorHealthcare
IndustryMedical Devices
Employees682
Founded1990
Ipo Date2021-07-23
CeoWenbin Jiang
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price17.00
IsinUS23285D1090
Cusip23285D109
Cik1831915
Sic3826
Stock TypeCommon Stock

Key executives

NameTitle
Dr. Wenbin Jiang Ph.D.President, Chief Executive Officer and Chairman of the Board
William D. McCombeChief Financial Officer
Dr. Ming Yan Ph.D.Chief Technology Officer and Director
Paul D. GoodsonHead of Investor Relations
Ilan B. FeuchtwangChief Legal Officer
Patrik Sebastian JeanmonodHead of Corporate Development Analytics

Contact

Address47215 Lakeview Blvd, Fremont, California 94538-6407, United States
Phone877 922 9835
Websitehttps://cytekbio.com